Literature DB >> 13679444

Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases.

Jerzy Lasota1, Bartek Wasag, Agnieszka Dansonka-Mieszkowska, Danuta Karcz, Carl L Millward, Janusz Ryś, Jerzy Stachura, Leslie H Sobin, Markku Miettinen.   

Abstract

A significant percentage of conventional schwannomas, whether sporadic or associated with neurofibromatosis 2 (NF2), show loss of heterozygosity (LOH) at NF2 and/or NF2 inactivating mutations. Similarly, a significant percentage of neurofibromas show LOH at NF1 and/or NF1 inactivating mutations. There are no molecular genetic data on gastrointestinal (GI) nerve sheath tumors traditionally diagnosed as benign schwannomas, rare neoplasms possibly derived from the schwannian elements dispersed between the smooth muscle fibers. In this study, we analyzed 1 esophageal, 16 gastric, 1 small intestinal, and 2 colonic tumors of such type. Histologically, all were spindle cell neoplasms positive for S-100 protein, vimentin, and glial fibrillary acidic protein, and negative for smooth muscle markers, KIT, CD34, neurofilament proteins, and HMB45. Focal or extensive lymphoid cuffs, often containing germinal centers, were present in most cases. None of the patients had NF2 or NF1. Chromosomes 22 and 17, particularly NF2 and NF1 loci, were analyzed for LOH in all GI tumors and for comparative purposes in 10 conventional schwannomas. LOH on 22q was seen in 40% of conventional schwannomas but in only 5% (1 of 20) of GI schwannomas. PCR amplification followed by direct sequencing of PCR products failed to identify mutations in NF2 coding sequences (exons 1-15) in 13 cases, including a case with LOH on 22q. Losses on 17q involving NF1 were seen in both GI and conventional schwannomas in 50% and 33% of analyzed tumors, respectively. LOH at NF1 might be one of the genetic features seen in peripheral nerve sheath tumors from different locations and should be interpreted with caution. However, lack of NF2 alterations strongly supports the hypothesis that GI schwannomas represent a morphologically and genetically distinct group of peripheral nerve sheath tumors that are different from conventional schwannomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679444     DOI: 10.1097/01.lab.0000087591.29639.e3

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  16 in total

Review 1.  Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems.

Authors:  Fausto J Rodriguez; Andrew L Folpe; Caterina Giannini; Arie Perry
Journal:  Acta Neuropathol       Date:  2012-02-12       Impact factor: 17.088

2.  Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling.

Authors:  Ming Quan; Jiujie Cui; Tian Xia; Zhiliang Jia; Dacheng Xie; Daoyan Wei; Suyun Huang; Qian Huang; Shaojiang Zheng; Keping Xie
Journal:  Cancer Res       Date:  2015-10-19       Impact factor: 12.701

3.  Gastrointestinal schwannoma: an unusual colonic lesion mimicking adenocarcinoma.

Authors:  Brent K Wilde; Jenna-Lynn Senger; Rani Kanthan
Journal:  Can J Gastroenterol       Date:  2010-04       Impact factor: 3.522

Review 4.  Gastric schwannoma: a clinicopathologic study of 51 cases and critical review of the literature.

Authors:  Lysandra Voltaggio; Rebecca Murray; Jerzy Lasota; Markku Miettinen
Journal:  Hum Pathol       Date:  2011-12-01       Impact factor: 3.466

5.  Gastrointestinal stromal tumors: a clinicopathologic and immunohistochemical study of 136 cases.

Authors:  Zsolt Orosz; Tamás Tornóczky; Zoltán Sápi
Journal:  Pathol Oncol Res       Date:  2005-03-31       Impact factor: 3.201

6.  Loss of tumor suppressor Merlin in advanced breast cancer is due to post-translational regulation.

Authors:  K Adam Morrow; Shamik Das; Brandon J Metge; Keqiang Ye; Madhuri S Mulekar; J Allan Tucker; Rajeev S Samant; Lalita A Shevde
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

7.  Peripheral nerve sheath tumors of the gastrointestinal tract: a multicenter study of 58 patients including NF1-associated gastric schwannoma and unusual morphologic variants.

Authors:  Abbas Agaimy; Bruno Märkl; Julia Kitz; Peter H Wünsch; Hans Arnholdt; Laszlo Füzesi; Arndt Hartmann; Runjan Chetty
Journal:  Virchows Arch       Date:  2010-02-13       Impact factor: 4.064

8.  Clinicopathological features of esophageal schwannomas in mainland China: systematic review of the literature.

Authors:  Zi-Ye Gao; Xiao-Bo Liu; Sandeep Pandey; Bo Gao; Ping Liu; Qing-Hui Zhang; Yuan-Jun Gao; Sheng-Bao Li
Journal:  Int J Clin Oncol       Date:  2020-11-20       Impact factor: 3.402

Review 9.  Solitary schwannoma of the gallbladder: a case report and literature review.

Authors:  Lin-Na Liu; Hui-Xiong Xu; Shu-Guang Zheng; Li-Ping Sun; Le-Hang Guo; Jian Wu
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

10.  Extrahepatic biliary schwannomas: a case report.

Authors:  Ji Heon Jung; Kwang Ro Joo; Myung Jong Chae; Jae Young Jang; Sang Gil Lee; Seok Ho Dong; Hyo Jong Kim; Byung-Ho Kim; Young Woon Chang; Joung Il Lee; Rin Chang; Youn Hwa Kim; Sang Mock Lee
Journal:  J Korean Med Sci       Date:  2007-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.